medigraphic.com
Colegio de Medicina Interna de México.

2011, Number 2

<< Back Next >>

Med Int Mex 2011; 27 (2)

Percutaneous coronary intervention vs cardiac revascularization in trivascular disease or left main coronary artery

Esquivel MCG, Valdez DRV, López ME, García CIL, Flores YE, Ramírez GJR, Chávez LL

Language: Spanish
References: 17
Page: 120-126
PDF size: 346.26 Kb.


ABSTRACT

Background: Percutaneous coronary intervention (PCI) is being used more frequently in patients with lesions or TCI trivascular since it has better drug-eluting stents, despite the Cardiac Revascularization (CR) has been treating choice historically.
Objective: To compare the results of PCI vs CR in patients with LMCA or trivascular disease.
Material and Methods: retrospective, descriptive study realized in UMAE No. 71 IMSS Torreón, Coahuila, Mexico. We collected socio-demographic data of patients undergoing PCI or CR through clinical records for the last 3 years, with inclusion criteria trivascular disease or left main coronary artery disease (LMCA) disease diagnosed by coronary angiography, to assess prognosis through the SYNTAX score and survival at 12 months. Statistical package used Microsoft Office Excel and SPSS, v15.
Results: We analyzed 20 patients with LMCA disease or trivascular disease, obstructive lesion ≥ 50% demonstrated by coronary angiography, DS age 59 ± 9.8, 6 (30%) and women (70%) males. Smoking was (100%), 7 Diabetes, 13 hypertension, 8 dyslipidemia. A 10 patients were practical (ICP) and 10 RM. Regarding the SYNTAX Score, ICP = score› 33, 5 (25%) patients with MRI score› 33, 4 (25%). Individuals ICP with syntax score high in relation to MRI. There was only one death.
Conclusions: CABG subjects survived at 100% at 1 year.


REFERENCES

  1. Serruys P, Morice M, Kappetein P, et al. Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease. N Engl J Med 2009;360:961- 972.

  2. Boden WE, O’Rourke RA, Teo KK, Hartigan PM, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 2007;356:1503-1516.

  3. Taggart D. The DELFT (Drug Eluting stent for LeFT main) Registry: The Unknowns. J Am Coll Cardiol 2008;52:1680- 1681.

  4. Serruys PW, Ong ATL, Morice MC, De Bruyne B, et al. Arterial Revascularization Therapies Study Part II -Sirolimus-eluting stents for the treatment of patients with multivessel de novo coronary artery lesions. EuroIntervention 2005;1:147-156.

  5. Serruys PW, Unger F, Sousa JE, Jatene A, et al. Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med 2001;344:1117-1124.

  6. Seung K, Park D, Kim Y, et al. Stents versus Coronary-Artery Bypass Grafting For Left Main Coronary Artery Disease. N Engl J Med 2008;358:1781-1792.

  7. Brodie BR, Stuckey T, Downey W, Humphrey A, et al. Outcomes and complications with off-label use of drug-eluting stents: Results from the STENT (Strategic Transcatheter Evaluation of New Therapies) Group. J Am Coll Cardiol Intv 2008;1:405-414.

  8. Sianos G, Morel Ma, Kappetein AP, et al. The SYNTAX score: an angiographic tool grading the complexity of coronary artery disease. Eurointervention 2005;1:219-227.

  9. Hannan EL, Wu C, Walford G, et al. Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease. N Engl J Med 2008;358:331-341.

  10. Bravata DM, Gienger AL, McDonald KM, et al. Systematic review: the comparative effectiveness of percutaneous coronary interventions and coronary artery bypass graft surgery. Ann Intern Med 2007;147:703-716.

  11. Meliga E, García-García HM, Valgimigli M, Chieffo A, et al. Longest available clinical outcomes after drug-eluting stent implantation for unprotected left main coronary artery disease: The DELFT (Drug Eluting stent for LeFT main) Registry. J Am Coll Cardiol 2008;51:2212-2219.

  12. Seung KB, Park DW, Kim YH, Lee SW, et al. Stents versus coronary-artery bypass grafting for left main coronary artery disease. N Engl J Med 2008;358:1781-1792.

  13. Buszman PE, Kiesz SR, Bochenek A, Peszek-Przybyla E, et al. Acute and late outcomes of unprotected left main stenting in comparison with surgical revascularization. J Am Coll Cardiol 2008;51:538-5345.

  14. Mehilli J, Kastrati A, Byrne RA, Bruskina O, et al. Paclitaxelversus sirolimus-eluting stents for unprotected left main coronary artery disease. J Am Coll Cardiol 2009;10:1016.

  15. Serruys P, Garg S, y col. Intervencionismo coronario para todos los pacientes con enfermedad compleja: enfermedad de tres vasos o del tronco coronario izquierdo. Rev Esp Cardiol 2009; 62(7):719-725.

  16. Syntax Score. http://www.syntaxscore.com/ . Acceso 20 de Octubre de 2010.

  17. Riera M, Carrillo A, Ibáñez J, Sáez de Ibarra JI, y col. Valor predictivo del modelo EuroSCORE en la cirugía cardíaca de nuestro centro. Med Intensiva 2007;31(5):231-236.




2020     |     www.medigraphic.com